SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix’s special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedi ...

NEW YORK, Sept. 6, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Augmedix, Inc. (Nasdaq: AUGX), relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cash pe ...

Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this company would post a loss of $0.12 per share when it actually produced a loss of $0.12, delivering no surprise.Over the last four quarters, the company has surpassed consens ...

医疗文档自动化技术 - 公司提供行业领先的环境感知AI医疗文档技术,通过环境智能减轻医生的行政负担,让医生有更多时间专注于患者护理[120] - 公司的产品通过移动设备如智能手机访问,利用语音转文字、专有自然语言处理模型、大型语言模型和结构化数据集生成医疗笔记[121] - 公司的产品可以提供医疗笔记以外的附加价值,如开放生态系统的数字健康解决方案、实时提供诊疗过程中的关键数据、将非结构化数据转化为结构化数据并直接上传至医疗系统[122] - 公司的技术愿景是通过环境感知AI文档和数据解决方案,减轻医生的行政负担,让他们能够专注于患者护理[125] - 公司提供多种产品组合,满足不同医生对自动化程度的需求,有完全AI生成的医疗笔记,也有AI生成后由医疗文档专家进行编辑和审核的产品[126] 业务发展 - 公司服务于门诊诊所、专科医疗中心、医院和远程医疗平台等各类医疗场景,约85%的订阅医生隶属于医疗企业[123] - 公司每周向客户交付约70,000份医疗笔记,估计可为医生每天节省多达3小时的时间[124] - 公司与Commure Inc.签订合并协议,Commure将以每股2.35美元的价格收购公司[127] - 公司推出Augmedix Go和Augmedix Go Assist新产品,提供了更低的固定订阅费用和更低的收入成本[136] 财务表现 - 公司毛利率有所提升,预计未来将继续提高[137,138,139] - 公司总体收入增长率有所放缓,但Augmedix Go和Augmedix Go Assist将带来更高的未来收入增长[136] - 公司三个月和六个月的收入分别增长27%和33%,主要由于平均服务临床医生人数增加22%和29%[146,155] - 公司三个月和六个月的毛利率分别为47.2%和47.2%,较去年同期有所提升[147,156] - 公司三个月和六个月的研发费用分别增加71%和56%,主要用于加大工程和产品人员投入[150,154] - 公司三个月和六个月的销售及营销费用分别增加42%和40%,主要用于扩大销售及营销团队[149,154] - 公司三个月和六个月的一般及行政费用分别增加47%和38%,主要用于支付收购交易相关的法律及专业费用[148,154] - 公司三个月和六个月的其他收益分别增加95%和21%,主要来自孟加拉政府的投资补助[152,154] - 一般及行政费用增加340万美元至1240万美元,主要由于工资成本增加160万美元和其他费用增加180万美元[157] - 销售及营销费用增加210万美元至730万美元,主要由于销售和营销团队人员增加和薪资上涨[158] - 研发费用增加300万美元至830万美元,主要由于工程和产品团队人员增加[159] - 利息费用增加30万美元至130万美元,利息收入增加50万美元至90万美元[160] - 公司现金及现金等价物为2820万美元,预计现金余额可满足未来12个月的营运需求[163] 风险因素 - 孟加拉国持续的社会动荡影响了公司在孟加拉国的部分运营,未来可能对公司业务产生重大不利影响[129]

SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended June 30, 2024. “We believe we are approaching the proposed combination with Commure, Inc. from a position of strength, with consistent double-digit revenue growth and improving gross margins,” commented Manny Krakaris, Augmedix CEO. “Together, we believe we will be well-positioned to continue to streamline the m ...

SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference c ...

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Augmedix, Inc. (Nasdaq: AUGX), relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cas ...

Amid a sea of red in today’s stock market, AI medical documentation and data solutions company Augmedix (NASDAQ:AUGX) is certainly among the standout winners. Shares of AUGX stock have skyrocketed 150% in afternoon trading on a rather substantial announcement.The company is set to combine with healthcare technology company Commure in a $139 million deal. Investors will receive $2.35 per share in an all-cash transaction. Accordingly, with shares now trading just pennies shy of this price, it appears the mark ...

MILWAUKEE, July 19, 2024 /PRNewswire/ -- Ademi LLP is investigating Augmedix (Nasdaq: AUGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Commure.Click here to learn how to join our investigation https://www.ademilaw.com/case/augmedix-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.Augmedix stockholders will receive only $2.35 per share in an all-cash transaction that values Augmedix at approximately $139 million in equity ...

SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the prop ...